Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib

Lignende værker

• Modulation of the Antitumor Activity of Metronomic Cyclophosphamide by the Angiogenesis Inhibitor Axitinib
  af: Ma, Jie, et al.
  Udgivet: (2008)
• Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
  af: Hu, D E, et al.
  Udgivet: (1995)
• Combination of Anti-angiogenesis with Chemotherapy for More Effective Cancer Treatment
  af: Ma, Jie, et al.
  Udgivet: (2008)
• Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents
  af: Wang, Jinfeng, et al.
  Udgivet: (2017)
• Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
  af: Qin, Shuang, et al.
  Udgivet: (2019)